Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Diabetes mellitus: simple classification and corresponding treatment].

S Simsek1, M Diamant, E M W Eekhoffen

  • 1VU Medisch Centrum, afd. Endocrinologie/Diabetescentrum, Postbus 7057, I007 MB Amsterdam. simsek@vumc.nl

Nederlands Tijdschrift Voor Geneeskunde
|May 24, 2006
PubMed
Summary

Accurate diabetes mellitus classification is crucial for effective treatment and prognosis. This study presents a diagnostic flowchart to aid clinicians in distinguishing between diabetes types, including type 1, maternally inherited diabetes and deafness (MIDD), and maturity onset diabetes of the young (MODY).

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. (A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes)].

Problemy endokrinologii·2019
Same author

Exenatide twice-daily does not affect renal function or albuminuria compared to titrated insulin glargine in patients with type 2 diabetes mellitus: A post-hoc analysis of a 52-week randomised trial.

Diabetes research and clinical practice·2019
Same author

Influence of prednisolone on parameters of de novo lipogenesis and indices for stearoyl-CoA- and Δ6- desaturase activity in healthy males: A Post-hoc analysis of a randomized, placebo-controlled, double-blind trial.

Prostaglandins, leukotrienes, and essential fatty acids·2018
Same author

Acute plasma amylase increase after glucagon-like peptide -1 receptor agonist exenatide administration in Type 2 diabetes.

Diabetic medicine : a journal of the British Diabetic Association·2016
Same author

Effectiveness of insulin therapy in people with Type 2 diabetes in the Hoorn Diabetes Care System.

Diabetic medicine : a journal of the British Diabetic Association·2016
Same author

Glucagon-like peptide-1 receptor agonist exenatide has no acute effect on MRI-measured exocrine pancreatic function in patients with type 2 diabetes: a randomized trial.

Diabetes, obesity & metabolism·2015

Area of Science:

  • Endocrinology
  • Genetics
  • Metabolic Diseases

Context:

  • Diabetes mellitus classification presents diagnostic challenges impacting treatment and prognosis.
  • Distinguishing between diabetes types is essential for appropriate clinical management.
  • Genetic and clinical factors play a significant role in diabetes heterogeneity.

Purpose:

  • To develop and present a practical flowchart for classifying diabetes mellitus.
  • To assist clinicians in differentiating between various diabetes subtypes based on patient presentation.
  • To improve the accuracy of diabetes diagnosis for optimized patient care.

Summary:

  • The study outlines a diagnostic approach for diabetes mellitus, starting with acute hyperglycemia and low BMI suggesting type 1 diabetes.

Related Experiment Videos

  • For patients with mild symptoms and family history, deafness indicates maternally inherited diabetes and deafness (MIDD), while its absence suggests maturity onset diabetes of the young (MODY).
  • Body Mass Index (BMI) aids in classifying cases with non-acute hyperglycemia and no clear family history, facilitating treatment decisions.

    • Impact:

    • Provides a clear, actionable tool for clinicians managing hyperglycemic patients.
    • Enhances diagnostic accuracy, leading to more targeted and effective diabetes treatments.
    • Contributes to a better understanding of diabetes heterogeneity and its clinical implications.